Tag Archives: Concert Pharmaceuticals
Concert Pharmaceuticals Plans CTP-543 Phase 3 trials in Alopecia Areata
Concert Pharmaceuticals is planning to proceed with its Phase 3 trials of CTP-543 in patients with moderate-to-severe alopecia areata, an...